Pharmaceuticals, Biotechnology and Life Sciences
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that it will host a conference call and webcast to report its…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Checkmate Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat cancer, today…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
– Continued progress towards 2022 vision of four marketed gene and cell therapy products with robust development pipeline – –…
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the…
New analyses from filgotinib clinical development program reinforce the investigational medicine’s consistent efficacy and safety profile in the treatment of…
CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference in November:…
DUBLIN–(BUSINESS WIRE)–The “Alopecia Areata: Opportunity Analysis and Forecasts to 2028” report has been added to ResearchAndMarkets.com’s offering. The main driver…
Streamlined, rapid and reliable HPLC and LC-MS ready Sample Preparation of O-glycans HUDSON, N.H.–(BUSINESS WIRE)–S-Bio US today announced the launch…
DUBLIN–(BUSINESS WIRE)–The “Prostate Cancer: Global Drug Forecast and Market Analysis to 2028” report has been added to ResearchAndMarkets.com’s offering. The…